the firm's post-grant practitioners are some of the most experienced in the country.

Technologies

Artificial Intelligence (AI)
Artificial Intelligence (AI)
Digital Health
Digital Health
Energy & Renewables
Energy & Renewables

Fast Facts

About Our

Law Firm

About Our Law Firm

Headquartered within steps of the USPTO with an affiliate office in Tokyo, Oblon is one of the largest law firms in the United States focused exclusively on intellectual property law.

Get to know our

History

Get to know our History

1968
Norman Oblon with Stanley Fisher and Marvin Spivak launched what was to become Oblon, McClelland, Maier & Neustadt, LLP, one of the nation's leading full-service intellectual property law firms.

Our Local and

Global Reach

Our Local and Global Reach

Outside the US, we service companies based in Japan, France, Germany, Italy, Saudi Arabia, and farther corners of the world. Our culturally aware attorneys speak many languages, including Japanese, French, German, Mandarin, Korean, Russian, Arabic, Farsi, Chinese.

A few of our

ACCOLADES

A few of our ACCOLADES

Oblon's professionals provide industry-leading IP legal services to many of the world's most admired innovators and brands.

OPPORTUNITIES FOR YOUR

Career

OPPORTUNITIES FOR YOUR Career

From the minute you walk through our doors, you'll become a valuable part of a team that fosters a culture of innovation, client service and collegiality.

A few ways to

GET In Touch

A few ways to GET In Touch
US Office

Telephone: 703-413-3000
Learn More +


Tokyo Office

Telephone: +81-3-6212-0550
Learn More +

Downloadable

Patent Forms

Downloadable Patent Forms

The United States Patent and Trademark Office (USPTO) issued final rules implementing the inventor's oath or declaration provisions of the America Invents Act (AIA) on August 14, 2012.

Stay informed with

Our Blogs

CAFC Affirms Post-AIA Invalidity of Process Claims Based on Sale of Product Made by Claimed Process

  • August 15, 2025
  • Article

Associated People


The U.S. Court of Appeals for the Federal Circuit (CAFC) recently affirmed the International Trade Commission's (ITC) decision in Celanese International Corp. v. ITC, ruling that Celanese's process claims were invalid due to secret sales of products made by the claimed process prior to the one-year on-sale bar, as codified in 35 U.S.C. § 102(a). This decision followed the Supreme Court's reasoning in Helsinn Healthcare v. Teva Pharmaceuticals (2019), rejecting Celanese's argument that the America Invents Act (AIA) altered the on-sale bar to exclude sales of products made by undisclosed processes.

The case arose from an ITC investigation into sweeteners imported by a Chinese manufacturer, which allegedly infringed Celanese's patents. It was undisputed that Celanese's process was used in Europe, resulting in sales by Celanese of the sweetener more than a year before the patents' effective filing date. The ITC found the process claims invalid, concluding that the AIA did not change the on-sale bar's interpretation.

On appeal, the Federal Circuit emphasized that the on-sale bar has been part of U.S. patent law since the Patent Act of 1836, consistently interpreted to include sales of products made by a secret process. The court cited prior cases where patent claims were invalidated due to the commercial exploitation of a process more than a year before filing for patent rights.

Celanese argued that AIA's change of wording in Section 102(a)(1) from "invention" to "claimed invention" and the addition of "otherwise available to the public" meant the process itself must be sold or publicly disclosed to invalidate the patent. The Federal Circuit rejected these arguments, noting that the changes were clerical and did not alter the established interpretation of the on-sale bar. Additionally, the one-year grace period for public disclosures in Section 102(b)(1) did not apply, as Celanese's sales occurred outside this window.